Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical device
|
| gptkbp:CEO |
gptkb:Jim_Schuermann
|
| gptkbp:focusesOn |
neuromodulation
spinal cord stimulation |
| gptkbp:foundedYear |
2013
|
| gptkbp:founder |
gptkb:John_Parker
|
| gptkbp:headquartersLocation |
gptkb:Sydney,_Australia
|
| https://www.w3.org/2000/01/rdf-schema#label |
Saluda Medical
|
| gptkbp:industry |
medical devices
|
| gptkbp:investor |
gptkb:Redmile_Group
gptkb:Medtronic gptkb:Action_Potential_Venture_Capital gptkb:KCK_Group |
| gptkbp:officeLocation |
gptkb:Minneapolis,_Minnesota,_USA
gptkb:San_Francisco,_California,_USA |
| gptkbp:product |
gptkb:Evoke_Spinal_Cord_Stimulator
|
| gptkbp:regulates |
FDA approval (Evoke System, 2022)
|
| gptkbp:specializesIn |
chronic pain management
|
| gptkbp:technology |
closed-loop spinal cord stimulation
|
| gptkbp:website |
https://www.saludamedical.com/
|
| gptkbp:bfsParent |
gptkb:Catherine_Livingstone
|
| gptkbp:bfsLayer |
6
|